Literature DB >> 7580533

Chemotherapy for non-small cell lung cancer.

D P Carbone, J D Minna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7580533      PMCID： PMC2550912          DOI： 10.1136/bmj.311.7010.889

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Resistance to cisplatin: how to deal with the problem?

Authors:  J L Canon; Y Humblet; M Symann
Journal:  Eur J Cancer       Date:  1990-01       Impact factor: 9.162

2.  Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.

Authors:  G Bonadonna; P Valagussa; A Moliterni; M Zambetti; C Brambilla
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

3.  Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

Authors:  C M Tsai; K T Chang; R P Perng; T Mitsudomi; M H Chen; C Kadoyama; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1993-06-02       Impact factor: 13.506

4.  A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

Authors:  J A Roth; F Fossella; R Komaki; M B Ryan; J B Putnam; J S Lee; H Dhingra; L De Caro; M Chasen; M McGavran
Journal:  J Natl Cancer Inst       Date:  1994-05-04       Impact factor: 13.506

5.  A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

Authors:  R Rosell; J Gómez-Codina; C Camps; J Maestre; J Padille; A Cantó; J L Mate; S Li; J Roig; A Olazábal
Journal:  N Engl J Med       Date:  1994-01-20       Impact factor: 91.245

6.  Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines.

Authors:  A F Gazdar; C Kadoyama; D Venzon; J G Park; C M Tsai; R I Linnoila; J L Mulshine; D C Ihde; G Giaccone
Journal:  J Natl Cancer Inst Monogr       Date:  1992

7.  c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer.

Authors:  H B Muss; A D Thor; D A Berry; T Kute; E T Liu; F Koerner; C T Cirrincione; D R Budman; W C Wood; M Barcos
Journal:  N Engl J Med       Date:  1994-05-05       Impact factor: 91.245
  7 in total
  6 in total

Review 1.  Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer.

Authors:  S Noble; K L Goa
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

2.  Chemotherapy in non-small cell lung cancer. It may not be ethical to ask patients to participate in future trials.

Authors:  M Harding
Journal:  BMJ       Date:  1996-01-27

3.  Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.

Authors:  C A Carter; A Rajan; C Keen; E Szabo; S Khozin; A Thomas; C Brzezniak; U Guha; L A Doyle; S M Steinberg; L Xi; M Raffeld; Y Tomita; M J Lee; S Lee; J B Trepel; K L Reckamp; S Koehler; B Gitlitz; R Salgia; D Gandara; E Vokes; G Giaccone
Journal:  Ann Oncol       Date:  2016-01-22       Impact factor: 32.976

Review 4.  Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies.

Authors:  Corey A Carter; Karen Zeman; Regina M Day; Patrick Richard; Arnold Oronsky; Neil Oronsky; Michelle Lybeck; Jan Scicinski; Bryan Oronsky
Journal:  Oncotarget       Date:  2016-06-28

5.  Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation.

Authors:  Chang Sun; Zhuojun Zhang; Jingbo Qie; Yi Wang; Ji Qian; Jiucun Wang; Junjie Wu; Qiang Li; Chunxue Bai; Baohui Han; Zhiqiang Gao; Jibin Xu; Daru Lu; Li Jin; Haijian Wang
Journal:  Oncotarget       Date:  2018-05-08

6.  Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer.

Authors:  Ming Jia; Meiling Zhu; Mengyun Wang; Menghong Sun; Ji Qian; Fei Ding; Jianhua Chang; Qingyi Wei
Journal:  Oncotarget       Date:  2016-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.